How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Accelerating Kids’ Access to Care Act of 2025
Client: RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (S.752/H.R. 1509) and the Consolidated Appropriations Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · 3A
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Source: Senate LDA
| THE NATIONAL SOCIETY OF GENETIC COUNSELORS | 10 | 2024–2026 |
| CUREPSP, INC. | 9 | 2025–2026 |
| CIRCLE MEDICAL | 6 | 2023–2024 |
| AMERICAN TELEMEDICINE ASSOCIATION | 2 | 2021 |
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2025
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Strengthening the Vaccines for Children Program Act of 2026
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; Federal funding for primary immunodeficiency research; Federal newborn screening policies; H.R. 8425, Strengthening the Vaccines for Children Program Act.
PI Post Acute Access Act
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 8528 PI Post-Acute Access Act and policies to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Modernization Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Modernization Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Access to Genetic Counselor Services Act of 2026
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Access to Genetic Counselor Services Act of 2026
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Access to Genetic Counselor Services Act of 2026
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
SAFE Drugs Act of 2026
Client: ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Accelerating Kids’ Access to Care Act
Client: RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (S.752/H.R. 1509) and the Consolidated Appropriations Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telemental Health Care Access Act of 2023
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telemental Health Care Access Act of 2023
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telemental Health Care Access Act of 2024
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telemental Health Care Access Act of 2024
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: IMMUNE DEFICIENCY FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.
Accelerating Kids’ Access to Care Act of 2025
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids’ Access to Care Act of 2025
Client: EVERYLIFE FOUNDATION FOR RARE DISEASES · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), continuation of telehealth ERISA exemption, CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), continuation of telehealth ERISA exemption, CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Telehealth Expansion Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
CONNECT for Health Act of 2025
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Bring American Companies Home Act
Client: INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Access to Genetic Counselor Services Act of 2025
Client: THE NATIONAL SOCIETY OF GENETIC COUNSELORS · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Access to Genetic Counselor Services Act, H.R. 6280; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Policies pertaining to rare disease therapy development; upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization
FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; Federal funding for primary immunodeficiency research; Federal newborn screening policies; H.R. 8425, Strengthening the Vaccines for Children Program Act.
H.R. 8528 PI Post-Acute Access Act and policies to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.
Policies pertaining to rare disease therapy development; upcoming FDA Prescription Drug User Fee Act (PDUFA) reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · second_quarter · Q2
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; Federal funding for primary immunodeficiency research; Federal newborn screening policies.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions.
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Reauthorization of Pediatric Priority Review Voucher and the Consolidated Appropriations Act; Rare Disease Congressional Caucus; concerns regarding FDA review of rare disease therapies; hearing preparations.
FY 27 rare disease policy and programmatic requests pertaining to rare disease therapy development and research.
Accelerating Kids Access to Care Act (S.752/H.R. 1509) and the Consolidated Appropriations Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Access to Genetic Counselor Services Act, H.R. 6280/S. 3607; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · 1T
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2026 · first_quarter · Q1
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Access to Genetic Counselor Services Act, H.R. 6280; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · fourth_quarter · Q4
Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act; Activities related to PDUFA VIII; Concerns about FDA Complete Response Letters and other issues related to rare disease therapies; Activities of Congressional Rare Disease Caucus.
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
The Healthy Brains Act and issues related to neurodegenerative diseases, caregiving and investment in brain health.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Support for telehealth (HR 1650/S 763), CONNECT for Health Act (HR 4206/S 1261), Telemental Health Care Access Act (HR 3432/S3651; Telehealth Modernization Act (HR 508/S 2709).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
FY 26 primary immunodeficiency research and public health funding.
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act; Activities related to PDUFA VIII.
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · 2A
The Healthy Brains Act and Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · 2A
The Healthy Brains Act and Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Federal immunization and vaccine policies including changes to the ACIP and impact on the PI community; federal funding for primary immunodeficiency research; Reporting of NIH spending on primary immunodeficiency disease research; federal newborn screening policies.
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation; H.R. 1/One Big Beautiful Bill.
FY 26 primary immunodeficiency research and public health funding.
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · Q2
Implementation of FDA Rare Disease Innovation Hub; reauthorization of Pediatric Priority Review Voucher; reauthorization of Newborn Screening Saves Lives Act.
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation; H.R. 1, budget reconciliation/One Big, Beautiful Bill Act.
CUREPSP, INC. via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · second_quarter · RR
FY26 appropriation requests to support research and policies related to PSP, CBD and MSA; Public policies and issues pertaining to interagency coordination and management of PSP, CBD and MSA
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Access to Genetic Counselor Services Act; NIH funding; newborn screening; regulation of genetic testing and genetic counseling; Medicaid coverage; telehealth access; Reducing Hereditary Cancer Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), continuation of telehealth ERISA exemption, CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Support continuation of first-dollar coverage for telehealth (HR 1650/S 763), continuation of telehealth ERISA exemption, CONNECT for Health Act (S 1261), Telemental Health Care Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
Federal immunization and vaccine policy issues impacting the immunocompromised community; federal support for primary immunodeficiency research.
Legislation to address access to immunoglobulin during Medicare-covered Skilled Nursing Facility admissions; Medicaid and budget reconciliation.
FY 26 primary immunodeficiency research and public health funding.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2025 · first_quarter · Q1
2025 end-of-year healthcare package including reauthorization of the Pediatric Priority Review Voucher; legislation pertaining to FDA approval pathways; Implementation of FDA Rare Disease Innovation Hub.
FY 26 appropriations programmatic and report provisions pertaining to rare disease policy priorities.
Accelerating Kids Access to Care Act (H.R. 1509/S. 752) and related out-of-state Medicaid issues; Medicaid funding and budget reconciliation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S. 5271 BUPE for Recovery Act and H.R. 5526 Seniors Access to Critical Medications Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 9886/S.5271 BUPE for Recovery Act and H.R. 5526 Seniors' Access to Critical Medications Act.
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · 4A
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
H.R.3876/ S.2323 - Access to Genetic Counselor Services Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · 4A
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
Scientific meeting focused on improving diagnostics of PI.
Funding and related issue pertaining to improving diagnostics of PI; H.R. 5397, the Joe Fiandra Access to Home Infusion Act.
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
FY 25 appropriations legislation and provisions pertaining to coordination of rare disease activities within the FDA and HHS and funding for rare disease policies and programs including establishment of interagency rare disease coordinating committee.
Establishment of FDA Rare Disease Innovation Hub and related issues pertaining to rare disease therapy applications; reauthorization of the pediatric priority review voucher (H.R. 3433), Promising Pathways Act (S. 4426); Creating Hope Reauthorization Act of 2024 (S.4583).
Accelerating Kids' Access to Care Act (H.R. 4758, S. 2372) and issues pertaining to out-of-state care; Impact of Inflation Reduction Act on rare disease therapies.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · Q4
Scientific meeting focused on improving diagnostics of PI.
Funding and related issue pertaining to improving diagnostics of PI; H.R. 5397, the Joe Fiandra Access to Home Infusion Act.
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
THE NATIONAL SOCIETY OF GENETIC COUNSELORS via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · fourth_quarter · RR
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
H.R. 3876/S. 2323 Access to Genetic Counselor Services Act.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Funding and related issue pertaining to improving diagnostics of PI; FDA proposal to regulate Laboratory Developed Tests (LDTs); H.R. 5397, the Joe Fiandra Access to Home Infusion Act.
FY 25 report language pertaining to primary immunodeficiency disease medical research.
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act; Preserving Telehealth, Hospital, and Ambulance Access Act (HR 6364); Expanding Remote Monitoring Access Act (HR 53934); Sustainable Cardiopulmonary Rehabilitation (CR) Service in the Home Act (HR 1406).
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · third_quarter · Q3
Establishment of FDA Rare Disease Innovation Hub and related issues pertaining to rare disease therapy applications; reauthorization of the pediatric priority review voucher (H.R. 3433), Promising Pathways Act (S. 4426)
Accelerating Kids' Access to Care Act (H.R. 4758, S. 2372) and issues pertaining to out-of-state care; Impact of Inflation Reduction Act on rare disease therapies.
FY 25 appropriations legislation and provisions pertaining to coordination of rare disease activities within the FDA and HHS and funding for rare disease policies and programs including establishment of interagency rare disease coordinating committee.
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · 2T
Issues related to telehealth/telemedicine and pharmacies.
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Issues pertaining to FDA review of application for rare disease therapies; Issues pertaining to interagency coordination and management of rare disease activities; Legislation to reauthorize the Pediatric Priority Review Voucher; S. 4426 Promising Pathways Act
FY 25 appropriations legislation and provisions pertaining to coordination of rare disease activities within the FDA and HHS and funding for rare disease policies and programs.
Accelerating Kids' Access to Care Act (H.R. 4758, S. 2372) and issues pertaining to out-of-state care; Impact of Inflation Reduction Act on rare disease therapies.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Funding and related issue pertaining to primary immunodeficiency disease; FDA proposal to regulate Laboratory Developed Tests (LDTs); H.R. 5397, the Joe Fiandra Access to Home Infusion Act.
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
FY 25 report language pertaining to primary immunodeficiency disease medical research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act; Preserving Telehealth, Hospital, and Ambulance Access Act (HR 6364); Expanding Remote Monitoring Access Act (HR 53934); Sustainable Cardiopulmonary Rehabilitation (CR) Service in the Home Act (HR 1406).
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medical provider enrollment; S 3430 Better Mental Health care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 2548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
FY 24 and FY 25 programmatic and report language pertaining to rare disease medical research, therapy development and public health activities.
Issues pertaining to FDA review of application for rare disease therapies; Issues pertaining to interagency coordination and management of rare disease activities; Legislation to reauthorize the Pediatric Priority Review Voucher.
Accelerating Kids' Access to Care Act (H.R. 4758, S. 2372) and issues pertaining to out-of-state care; Impact of Inflation Reduction Act on rare disease therapies.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Funding and related issue pertaining to primary immunodeficiency disease.
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities
FY 25 report language pertaining to primary immunodeficiency disease medical research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine: H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act, Primary and Virtual Care Affordability Act, Expanding Remote Monitoring Access Act
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2024 · first_quarter · Q1
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Issues related to telehealth/telemedicine and pharmacies.
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Filing targets: Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities; implementation of permanent Medicare in-home IVIG bundled payment.
Opportunities to increase funding to support research into primary immunodeficiency diseases; H.R. 830 and S. 1375, the HELP Copays Act; Proposed FDA rule re: Laboratory Developed Test and implications for the PI community.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Implementation of drug negotiation policy and impact on rare disease populations.
FDA policies pertaining to development of rare disease therapies; rare disease education and awareness including activities via the Congressional Rare Disease Caucus; newborn screening program policy issues.
FY 24 appropriations requests pertaining to rare disease issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/ S 2433 SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · fourth_quarter · Q4
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment; S 3430 Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment; S 3430 Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, HR 5378 Lower Cost, More Transparency, S 3548 Health Care Prices Revealed and Information to Consumers Explained (PRICE) Transparency Act, S 3059 Requiring Enhanced & Accurate Lists of (REAL) Health Providers Act.
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: HOUSE OF REPRESENTATIVES
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
Opportunities to increase funding to support research into primary immunodeficiency diseases; H.R. 830 and S. 1375, the HELP Copays Act.
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities; implementation of permanent Medicare in-home IVIG bundled payment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
FDA policies pertaining to development of rare disease therapies; rare disease education and awareness including activities via the Congressional Rare Disease Caucus.
Implementation of drug negotiation policy and impact on rare disease populations.
FY 24 appropriations requests pertaining to rare disease issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · third_quarter · Q3
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
IMMUNE DEFICIENCY FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
H.R. 3017, the PI Post Acute Access Act and policies pertaining to access to immunoglobulin (Ig) treatments for Medicare beneficiaries within Skilled Nursing Facilities; implementation of permanent Medicare in-home IVIG bundled payment.
Opportunities to increase funding to support research into primary immunodeficiency diseases; H.R. 830 and S. 1375, the HELP Copays Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CIRCLE MEDICAL via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Issues related to telehealth/telemedicine, prescribing, and pharmacy dispensing of medications.
Issues related to telehealth/telemedicine and pharmacies.
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
EVERYLIFE FOUNDATION FOR RARE DISEASES via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
FY 24 appropriations requests pertaining to rare disease issues
Implementation of drug negotiation policy and impact on rare disease populations.
Issues pertaining to development of therapies for rare diseases including oversight of FDAs structure for rare disease applications; engagement on FDA guidance document; S. 1214, the RARE Act; activities of the Congressional Rare Disease Caucus.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ATA ACTION via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INCLUDED HEALTH (FORMERLY GRAND ROUNDS HEALTH) via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · second_quarter · Q2
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment.
Continuation of first-dollar coverage for telehealth H.R. 1843, S. 1001 - Telehealth Expansion Act; Telehealth ERISA exemption H.R. 824 Telehealth Benefit Expansion for Workers Act; CONNECT for Health Act; Telemental Health Care Access Act; health care data transparency; telehealth in Medicare Advantage; streamlining Medicaid provider enrollment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2023 · first_quarter · Q1
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Medication safety, pharmacy regulation and licensure, drug supply chain security, and combatting the opioid epidemic; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth.
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; SHOP SAFE Act; Cooper Davis Act; Protecting Patients from Deceptive Drug Ads Act (S. 652).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 25 report language pertaining to primary immunodeficiency disease medical research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 25 report language pertaining to primary immunodeficiency disease medical research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.
S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE